The death of a young Japanese reality TV star targeted by online abuse has sparked an outpouring of grief in the country and calls for stronger measures to tackle cyberbullying. The apparent suicide ... ( read original story ...)
Japan’s low unemployment rate conceals deeper labour market pain
Japan's labour market in April appeared to be weathering a severe slowdown in economic activity due to the coronavirus pandemic, but a closer look at official data released on Friday revealed a less ... ( read original story ...)
Crashed Pakistan A320 jet insured for $19.7 million: airline document
Airbus SE A320 jet that crashed into a crowded residential district of Karachi last week killing 97 people on board was insured for $19.7 million, an airline document showed. ( read original story ...)
Indonesia minister slammed for ‘virus is like your wife’ remarks
An Indonesian minister is under fire after he compared coronavirus to rebellious wives, in remarks aimed at soothing public fears about easing COVID-19 restrictions across the Southeast Asian ... ( read original story ...)
Coronavirus Cases Soar Amid Reopenings in India and Beyond: Live Coverage
Doctors fear a lockdown that began two months ago is being eased too soon. In Indonesia, the caseload has doubled since early May to nearly 25,000. ( read original story ...)
No call between Trump and India’s Modi on China border tension: official source
Indian Prime Minister Narendra Modi has not spoken with U.S. President Donald Trump about the south Asian nation's military standoff with China, a government source said on Friday, after Trump ... ( read original story ...)
AP Explains: What’s behind latest India-China border tension
India border high in the Himalayas have flared again in recent weeks. Indian officials say the latest row began in early May, when Chinese soldiers entered the Indian-controlled territory of Ladakh at ... ( read original story ...)
India’s Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients
Drugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesilate in COVID-19 patients. ( read original story ...)
Sun Pharma to test pancreatitis drug in COVID-19 patients in India
Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indian regulatory approval to start clinical trials of a pancreatitis drug in COVID-19 patients. The company joins other Indi ... ( read original story ...)
Its Coronavirus Caseload Soaring, India Is Reopening Anyway
Worried for its economy, India loosened tough restrictions and may lift them entirely this weekend. But infection numbers are climbing fast. ( read original story ...)